Dr. Stephen Jones takes on some of the questions you might have about AROMASIN® (exemestane tablets). Hear helpful answers about who AROMASIN is for, how it works, and more. His advice could even help you make the most of your visits to your doctor.
Dr. Jones is Medical Director of US Oncology Research in Houston, Texas. He's also the Director of Breast Cancer Research at the Baylor-Sammons Cancer Center in Dallas, Texas. Dr. Jones was a principal investigator in the AROMASIN IES study.
While you may find Dr. Jones' answers helpful, they should not replace the advice of your own doctor. Your doctor will make the treatment decision that is right for you, based on your own unique needs.
Select a question to hear Dr. Jones' response.
To learn more about AROMASIN, please see the Full Prescribing and Patient Information.
AROMASIN® (exemestane tablets) is a prescription medicine for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer. Treatment with AROMASIN should begin after 2 to 3 years of tamoxifen, at which time tamoxifen should be discontinued. Treatment with AROMASIN should continue for 2 to 3 years (until the completion of a total of 5 years of adjuvant treatment with tamoxifen and AROMASIN).
AOU00471
